Full Text View
Tabular View
No Study Results Posted
Related Studies
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
This study has been completed.
Study NCT00064727   Information provided by National Institutes of Health Clinical Center (CC)
First Received: July 10, 2003   Last Updated: April 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congestive Heart Failure
Additional conditions recognized in this trial
Glucose Intolerance
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Glucose Metabolism Disorders
Heart Diseases
Hyperglycemia
Metabolic Diseases
Interventions listed in this trial
Avandia (Rosiglitazone)
Avanclia (Rosiqlitazone)
Additional drug interventions recognized in this trial
Rosiglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services